HIF1A and metastatic neoplasm: Mizobuchi et al. [51] reported that metastases were present in 61% of HIF-1α-positive OS patients, representing a 4.3-fold greater risk for having metastatic disease in patients with HIF-1α expression compared to that of HIF-1α-negative patients.